Julia E. Pedraza-Colunga

Facultad De Medicina Y Hospital Universitario Dr José Eleuterio González
Monterrey, NLE, Mexico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

High-Dose methotrexate in pediatric acute lymphoblastic leukemia: Variability across Mexican centers from a national survey.

High-Dose methotrexate in pediatric acute lymphoblastic leukemia: Variability across Mexican centers from a national survey.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: May 12, 2026

Early GVHD Prophylaxis to Prevent Cytokine Release Syndrome After Haploidentical Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-analysis.

Early GVHD Prophylaxis to Prevent Cytokine Release Syndrome After Haploidentical Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-analysis.

Journal: Transplantation and cellular therapy

Published: April 14, 2026

Early Graft-Versus-Host Disease Prophylaxis to Prevent Cytokine Release Syndrome after Haploidentical Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.

Early Graft-Versus-Host Disease Prophylaxis to Prevent Cytokine Release Syndrome after Haploidentical Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.

Journal: Transplantation and cellular therapy

Published: April 14, 2026

Corrigendum to 'Early Immunosuppression as CRS Prophylaxis in Outpatient Haploidentical Transplants: A Randomized Phase II Study' [Transplantation and Cellular Therapy volume 32 (2026) 11.e-11.e4/Article Number].

Corrigendum to 'Early Immunosuppression as CRS Prophylaxis in Outpatient Haploidentical Transplants: A Randomized Phase II Study' [Transplantation and Cellular Therapy volume 32 (2026) 11.e-11.e4/Article Number].

Journal: Transplantation and cellular therapy

Published: April 10, 2026

Corrigendum to 'Early Immunosuppression as CRS Prophylaxis in Outpatient Haploidentical Transplants: A Randomized Phase II Study' [Transplantation and Cellular Therapy volume 32 (2026) 11.e-11.e4/Article Number].

Corrigendum to 'Early Immunosuppression as CRS Prophylaxis in Outpatient Haploidentical Transplants: A Randomized Phase II Study' [Transplantation and Cellular Therapy volume 32 (2026) 11.e-11.e4/Article Number].

Journal: Transplantation and cellular therapy

Published: April 10, 2026

Optimizing Blinatumomab Access for Low- and Middle-Income Countries: Feasibility of a Shortened, Vial-Sharing, Outpatient Approach for Pediatric ALL.

Optimizing Blinatumomab Access for Low- and Middle-Income Countries: Feasibility of a Shortened, Vial-Sharing, Outpatient Approach for Pediatric ALL.

Journal: JCO global oncology

Published: February 20, 2026

Response to Correspondence Regarding "Early Immunosuppression as CRS Prophylaxis in Outpatient Haploidentical Transplants: A Randomized Phase II Study".

Response to Correspondence Regarding "Early Immunosuppression as CRS Prophylaxis in Outpatient Haploidentical Transplants: A Randomized Phase II Study".

Journal: Transplantation and cellular therapy

Published: February 06, 2026

Response to Correspondence Regarding "Early Immunosuppression as CRS Prophylaxis in Outpatient Haploidentical Transplants: A Randomized Phase II Study".

Response to Correspondence Regarding "Early Immunosuppression as CRS Prophylaxis in Outpatient Haploidentical Transplants: A Randomized Phase II Study".

Journal: Transplantation and cellular therapy

Published: February 06, 2026

Dynamics of Hospitalization and Early Mortality in an Outpatient Allogeneic Hematopoietic Cell Transplantation Program.

Dynamics of Hospitalization and Early Mortality in an Outpatient Allogeneic Hematopoietic Cell Transplantation Program.

Journal: Transplantation and cellular therapy

Published: July 31, 2025

Early Immunosuppression as CRS Prophylaxis in Outpatient Haploidentical Transplants: A Randomized Phase II Study.

Early Immunosuppression as CRS Prophylaxis in Outpatient Haploidentical Transplants: A Randomized Phase II Study.

Journal: Transplantation and cellular therapy

Published: June 19, 2025

Hodgkin and non-Hodgkin lymphomas in pediatric-age patients of Northeast Mexico: 18-year outcomes and survival rates at an academic center.

Hodgkin and non-Hodgkin lymphomas in pediatric-age patients of Northeast Mexico: 18-year outcomes and survival rates at an academic center.

Journal: Boletin medico del Hospital Infantil de Mexico

Published: May 20, 2025

Clinical and Economic Impact of the Mexico in Alliance With St. Jude Golden Hour Collaborative in a Mexican Hospital.

Clinical and Economic Impact of the Mexico in Alliance With St. Jude Golden Hour Collaborative in a Mexican Hospital.

Journal: Pediatric blood & cancer

Published: March 05, 2025

Showing 1-12 of 35

Last Updated: 09/26/2026